MetaVia Presents Data on DA-1241, a GPR119 Agonist, Demonstrating Both Hepatoprotective and Glucose-Regulating Effects in Patients with Presumed MASH, at the EASL Congress 2025

16 hours ago 2
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. MetaVia Presents Data on DA-1241, a GPR119 Agonist, Demonstrating Both Hepatoprotective and Glucose-Regulating Effects in Patients with Presumed MASH, at the EASL Congress 2025

Related

Pitney Bowes Q1 2025 slides: Profitability surges despite revenue dip

Pitney Bowes Q1 2025 slides: Profitability surges despite re...

2 hours ago 0
CrossAmerica Partners LP Reports First Quarter 2025 Results

CrossAmerica Partners LP Reports First Quarter 2025 Results

2 hours ago 0
Coherent Corp. Reports Third Quarter Fiscal 2025 Results

Coherent Corp. Reports Third Quarter Fiscal 2025 Results

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. axon stock
2. ionq stock
3. ucl final
4. flexport
5. amritsar
6. joe biden
7. marquinhos
8. reese witherspoon
9. alexandra eala
10. cvna stock

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

3 weeks ago 113
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

3 weeks ago 98
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

3 weeks ago 84
Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge Sours Investor Sentiment

Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge...

3 weeks ago 82
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

3 weeks ago 80
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved